课题基金 / 基金详情

CYR61 Expression and Function in rapidly progressive glomerulonephritis

CYR61 Expression and Function in rapidly progressive glomerulonephritis
CYR61 在急进性肾小球肾炎中的表达和功能
批准号:
16590792
负责人:
KOHDA Yukimasa
金额:
$2.11万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005

项目摘要

项目成果

KOHDA Yukimasa的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To certify the expression of CYR61 protein, 174 human renal biopsy samples were immuno-stained with anti-CYR61 antibody. 19 of 174 cases were rapidly progressive glomerulonephritis. 6 (30%) of 19 rapidly progressive glomerulonephritis showed positive reaction with anti-CYR61 Antibody. 4 cases showed positive reaction in cellular Crescents. 2 cases showed positive reaction in tubles. 25 (16.1%) of 155 chronic glomerulonephritis samples showed positive reaction with anti-CYR61 antibody. No reaction was seen in glomeruli of chronic glomerulonephritis samples. 25 positive samples showed the reaction in tubles. Serum creatinine was 7.2mg/dl in the patients of "crescent positive stained RPGN", and 4.3mg/dl in "crescent negative stained RPGN". There were no differences between both groups. In chronic Glomerular samples, CYR61 positive group had more severe interstitial damages compare to CYR61 negative group. But there were any clinical differences in both groups.Because of cross reactivity o … More f antibodies, CYR61 expression was checked by another method, RT-PCR. mRNA was extracted from frozen renal biopsy samples. Small amount of renal biopsy samples were quickly frozen at the time of renal biopsy for immuno-fluorescent staining. Several frozen tissue were cut in 5μm thickness and quickly fixed with 70% ethanol to remove OCT compound. After 5 minutes, tissue sections were quickly air dried and RNA was extracted by 4M GTC solution. RT reaction was performed and PCR was performed with this cDNA. By regular 35cycle PCR, CYR61 mRNA products were seen. By real time PCR, there was no relation between the clinical future and CYR expression. Several reason of this negative result were the quality of mRNA, number of samples, especially less number of rapidly progressive glomerulonephritis.To determine the urinaly expression of CYR61, sensitivity of Western Blot was not enough to see CYR61. Sample collection and concentration method should be changed.The Expression of CYR61 was seen in severe glomerulonephritis, rapidly progressive glomerulonephritis. Especially the reaction was seen in crescents in rapidly progressive glomerulonephritis samples. So CYR61 will perform some reaction in human rapidly progressive glomerulonephritis. Less
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间: 2005
期刊: Hypertens Res 8(8)
影响因子: --
作者: [Sakuma Y, Nonoguchi H, Takayama M, Yang T, Terada Y, Inoue T, Nakayama Y, Kohda Y, Sakaki S, Tomita K.]
通讯作者: Tomita K.
Regulation of aquaporin-2 by metabolic acidosis
代谢性酸中毒对 aquaporin-2 的调节
DOI: --
发表时间: 2004
期刊: Am J Physiol Cell Physiol 287
影响因子: --
作者: [Ohkouchi S, Nonoguchi H]
通讯作者: Nonoguchi H
Differential Effects of Hyperosmolality on Na-K-ATPase and Vasopressin- Dependent cAMP Genaration in the MTAL and OMCD.
高渗透压对 MTAL 和 OMCD 中 Na-K-ATP 酶和加压素依赖性 cAMP 生成的不同影响。
DOI: --
发表时间: 2005
期刊: Hypertens Res 28(8)
影响因子: --
作者: [Sakuma Y, Nonoguchi Y, Inoue T, Nakayama Y, Kohada et al.]
通讯作者: Kohada et al.
Long-term renoprotective effect of combination therapy with prostaglandin El and ACEI in patients with chronic renal failure.
前列腺素El和ACEI联合治疗对慢性肾功能衰竭患者的长期肾脏保护作用。
DOI: --
发表时间: 2005
期刊: Hypertens Res 28(9)
影响因子: --
作者: [Sakuma Y, Nonoguchi Y, Inoue T, Nakayama Y, Kohada et al.]
通讯作者: Kohada et al.
7
    Mechanism of kidney protection effect of alpha-Melanocyte stimulating hormone in ischemia reperfusion injury.
    • 批准号:
      14571028
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.18万
    • 财政年份:
      2002
    • 负责人:
      KOHDA Yukimasa
    • 依托单位:
    国内基金
    海外基金
    从Cyr61/ITGB4/ATG7介导的自噬途径研究生肌化瘀膏改善糖尿病溃疡慢性炎症分子机制
    • 批准号:
      82374444
    • 项目类别:
      面上项目
    • 资助金额:
      48万元
    • 批准年份:
      2023
    • 负责人:
      蒯仂
    • 依托单位:
    脊索瘤类软骨细胞亚群旁分泌CYR61因子诱导巨噬细胞M2型极化促进肿瘤进展的机制研究
    • 批准号:
      2023JJ40587
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2023
    • 负责人:
      黄维
    • 依托单位:
    TGF-β和YAP信号共同诱导的CYR61通过微环境肝星状细胞抑制肝细胞癌发展的机理研究
    • 批准号:
      32370765
    • 项目类别:
      面上项目
    • 资助金额:
      50万元
    • 批准年份:
      2023
    • 负责人:
      严晓华
    • 依托单位:
    负载KGN及SMSCs脂质体锚定的混合微凝胶通过CCN1/CYR61调控促进软骨修复的机制研究
    • 批准号:
      82102632
    • 项目类别:
      青年科学基金项目(C类)
    • 资助金额:
      30.0万元
    • 批准年份:
      2021
    • 负责人:
      许鉴
    • 依托单位: